DIVIS LABORATORIES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Dec-18* | 3 Sep-19* | 3 Dec-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 13,429 | 14,456 | 13,905 | -3.8% | 3.5% |
Other income | Rs m | 346 | 470 | 403 | -14.3% | 16.6% |
Turnover | Rs m | 13,775 | 14,926 | 14,308 | -4.1% | 3.9% |
Expenses | Rs m | 8,196 | 9,550 | 8,936 | -6.4% | 9.0% |
Gross profit | Rs m | 5,233 | 4,906 | 4,969 | 1.3% | -5.1% |
Depreciation | Rs m | 425 | 459 | 467 | 1.7% | 9.9% |
Interest | Rs m | 25 | 38 | 16 | -59.1% | -38.5% |
Profit before tax | Rs m | 5,129 | 4,879 | 4,889 | 0.2% | -4.7% |
Tax | Rs m | 1,334 | 1,311 | 1,282 | -2.2% | -3.9% |
Profit after tax | Rs m | 3,795 | 3,568 | 3,607 | 1.1% | -4.9% |
Gross profit margin | % | 39.0 | 33.9 | 35.7 | ||
Effective tax rate | % | 26.0 | 26.9 | 26.2 | ||
Net profit margin | % | 27.5 | 23.9 | 25.2 |
To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.
Get Details: First Stock to Potentially Accumulate Rs 7 Crore Long-term Wealth
Over the last one year,DIVIS LABORATORIES share price has moved up from Rs 1,654.1 to Rs 2,049.8, registering a Gain of Rs 395.7 or around 23.9%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,040.5 (up 0.7%). Over the last one year it has moved up from 13,863.1 to 14,040.5, a gain of 177 points (up 1.3%).
Overall, the S&P BSE SENSEX is up 12.4% over the year.
At the current price of Rs 2,049.8, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 42.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.8 times.
For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsIn this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More
| |
Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!